Genetic background modifies phenotypic and transcriptional responses in a C. elegans model of α-synuclein toxicity

article

Genetic background modifies phenotypic and transcriptional responses in a C. elegans model of α-synuclein toxicity is …
instance of (P31):
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1112902259
P356DOI10.1186/S12864-019-5597-1
P2888exact matchhttps://scigraph.springernature.com/pub.10.1186/s12864-019-5597-1
P932PMC publication ID6427842
P698PubMed publication ID30894116

P50authorMark G. SterkenQ55188426
Basten SnoekQ42616823
P2093author name stringJan E Kammenga
Simon C Harvey
Jana J Stastna
Joost A G Riksen
Yiru A Wang
P2860cites workAnti-Parkinsonian effects of Bacopa monnieri: insights from transgenic and pharmacological Caenorhabditis elegans models of Parkinson's disease.Q50511933
Genetic variation in strains of zebrafish (Danio rerio) and the implications for ecotoxicology studies.Q51678940
No association between 5 new GWAS-linked loci in Parkinson's disease and multiple system atrophy in a Chinese population.Q52565694
Suppression of in vivo beta-amyloid peptide toxicity by overexpression of the HSP-16.2 small chaperone protein.Q53290339
Natural genetic variation in identified genomic loci controlling metabolite levelsQ58776580
Genetic variation for stress-response hormesis in C. elegans lifespanQ84185490
What have worm models told us about the mechanisms of neuronal dysfunction in human neurodegenerative diseases?Q37389590
Discovery and functional prioritization of Parkinson's disease candidate genes from large-scale whole exome sequencingQ37615837
Natural Genetic Variation in the Caenorhabditis elegans Response to Pseudomonas aeruginosa.Q37746436
Genetic modifiers of neurological diseaseQ37830879
Caenorhabditis elegans as a platform for molecular quantitative genetics and the systems biology of natural variationQ37856452
Caenorhabditis elegans as an experimental tool for the study of complex neurological diseases: Parkinson's disease, Alzheimer's disease and autism spectrum disorderQ37954135
Worms under stress: C. elegans stress response and its relevance to complex human disease and aging.Q38083319
A rapid and massive gene expression shift marking adolescent transition in C. elegansQ38418687
A fitness assay for comparing RNAi effects across multiple C. elegans genotypesQ38918562
Widespread genetic incompatibility in C. elegans maintained by balancing selectionQ38987657
Distinct genetic forms of frontotemporal dementia.Q40059334
Lipid droplet binding and oligomerization properties of the Parkinson's disease protein alpha-synucleinQ40763309
Ras/MAPK Modifier Loci Revealed by eQTL in Caenorhabditis elegansQ41383342
Selection at linked sites shapes heritable phenotypic variation in C. elegansQ42257621
Using the mouse to model human disease: increasing validity and reproducibilityQ42599011
Genotype-dependent lifespan effects in peptone deprived Caenorhabditis elegansQ42747602
Genetic screens in Caenorhabditis elegans models for neurodegenerative diseasesQ43416117
Obesity and vascular risk factors at midlife and the risk of dementia and Alzheimer diseaseQ46745854
Temporal dynamics of gene expression in heat-stressed Caenorhabditis elegans.Q47108673
Hippocampal atrophy predicts conversion to dementia after STN-DBS in Parkinson's disease.Q48670515
The genetics of Caenorhabditis elegansQ24533408
Alpha-synuclein blocks ER-Golgi traffic and Rab1 rescues neuron loss in Parkinson's modelsQ24683059
Systemic Regulation of RAS/MAPK Signaling by the Serotonin Metabolite 5-HIAAQ27311127
Role of pleiotropy in the evolution of a cryptic developmental variation in Caenorhabditis elegansQ27320539
Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson's diseaseQ28244731
C. elegans model identifies genetic modifiers of alpha-synuclein inclusion formation during agingQ28472271
Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson's diseaseQ29614900
Maintenance of C. elegansQ29617844
limma powers differential expression analyses for RNA-sequencing and microarray studiesQ29617988
Dietary restriction suppresses proteotoxicity and enhances longevity by an hsf-1-dependent mechanism in Caenorhabditis elegansQ30488783
Widespread genomic incompatibilities in Caenorhabditis elegans.Q30593069
Contribution of trans regulatory eQTL to cryptic genetic variation in C. elegans.Q32175942
Mapping determinants of gene expression plasticity by genetical genomics in C. elegansQ33267908
The background puzzle: how identical mutations in the same gene lead to different disease symptomsQ33365189
A genome-wide library of CB4856/N2 introgression lines of Caenorhabditis elegans.Q33471263
Loss-of-function of β-catenin bar-1 slows development and activates the Wnt pathway in Caenorhabditis elegansQ33606421
Genetic variation in neurodegenerative diseases and its accessibility in the model organism Caenorhabditis elegansQ33729960
Global genetic robustness of the alternative splicing machinery in Caenorhabditis elegansQ34131586
Genome-wide gene expression regulation as a function of genotype and age in C. elegans.Q34619782
Natural variation for lifespan and stress response in the nematode Caenorhabditis remaneiQ34711930
Gene-environment and protein-degradation signatures characterize genomic and phenotypic diversity in wild Caenorhabditis elegans populationsQ34956179
The epidemiology of dementia associated with Parkinson diseaseQ35001358
Natural genetic variation determines susceptibility to aggregation or toxicity in a C. elegans model for polyglutamine diseaseQ35002352
Natural Genetic Variation Influences Protein Abundances in C. elegans Developmental Signalling Pathways.Q35960403
Parkinson's disease dementia: a neural networks perspectiveQ36186763
Proteomic analysis of age-dependent changes in protein solubility identifies genes that modulate lifespanQ36220305
Genetic variation in laboratory miceQ36299344
Hypothesis-based RNAi screening identifies neuroprotective genes in a Parkinson's disease modelQ36393015
Utility of an improved model of amyloid-beta (Aβ₁₋₄₂) toxicity in Caenorhabditis elegans for drug screening for Alzheimer's diseaseQ36460071
Natural Genetic Variation Differentially Affects the Proteome and Transcriptome in Caenorhabditis elegans.Q36876119
Beyond induced mutants: using worms to study natural variation in genetic pathways.Q37104190
Energy crisis precedes global metabolic failure in a novel Caenorhabditis elegans Alzheimer Disease modelQ37274022
P275copyright licenseCreative Commons Attribution 4.0 InternationalQ20007257
P6216copyright statuscopyrightedQ50423863
P4510describes a project that useslimmaQ112236343
P433issue1
P407language of work or nameEnglishQ1860
P921main subjectbiotechnologyQ7108
Caenorhabditis elegansQ91703
SynucleinQ24767155
P304page(s)232
P577publication date2019-03-20
P1433published inBMC GenomicsQ15765854
P1476titleGenetic background modifies phenotypic and transcriptional responses in a C. elegans model of α-synuclein toxicity
P478volume20

Reverse relations

cites work (P2860)
Q104286529Stressful development: Integrating endoderm development, stress, and longevity
Q89863572Unexpected cell type-dependent effects of autophagy on polyglutamine aggregation revealed by natural genetic variation in C. elegans
Q92794696WormQTL2: an interactive platform for systems genetics in Caenorhabditis elegans

Search more.